In One Sentence: Retatrutide, also known as Triple G, is a once-weekly injectable medication currently being researched for weight loss and Type 2 diabetes, showing promising results in early studies by targeting multiple metabolic pathways involved in appetite control and fat metabolism
The Trump administration scrapped a Biden-administration proposal to cover anti-obesity medications under Medicares Part D drug benefit, but it hasnt ruled out future coverage
It stimulates the proliferation and differentiation of satellite cells , which are essential for muscle repair and development (Florini et al., American Journal of Physiology )
By weeks six to eight, fatigue has either resolved entirely or settled into something much more manageable
Stanimirovic J, Radovanovic J, Banjac K, Obradovic M, Essack M, Zafirovic S, et al